OptimizeRx forecasts $95M-$100M 2026 revenue while maintaining $21M-$25M adjusted EBITDA amid pharma MFN disruption

When will OpenAI go public? Traders bet on Spring of 2027

2026/06/26

Infleqtion's neutral atom quantum approach prompts Outperform initiation from Wedbush

2026/06/26

Belden initiated with Buy rating at Citi

2026/06/26

2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off

2026/06/26